๎
๊ฒ์
์์ฅ
๋ด์ค
๋ถ์
๋๊ตฌ
์ข ๋ชฉ ์คํฌ๋ฆฌ๋
๋ ์์๋ณด๊ธฐ
๎ผ
์ค์บํ์ฌ ๋ค์ด๋ก๋
๋จ ํ๋์ ํ์ ์ค์ฝ์ด. ๋ ์ค๋งํธํ ํฌ์ ๊ฒฐ์ .
๎
English
็นไฝไธญๆ
เนเธเธข
Tiแบฟng viแปt
็ฎไฝไธญๆ
Espaรฑol
Portuguรชs
Deutsch
ํ๊ตญ์ด
๎ณ
ๆฅๆฌ่ช
๋ก๊ทธ์ธ
๋ฌด๋ฃ ํ์๊ฐ์
๎
๊ฒ์
๋ฌด๋ฃ ํ์๊ฐ์
๎
๎
์์ฅ๊ฐ
/
์ฃผ์
/
nasdaq-elvn
/
Enliven Therapeutics Inc
ELVN
๎ญ
๊ด์ฌ ๋ชฉ๋ก์ ์ถ๊ฐ
48.943
USD
-1.807
-3.56%
์์ฅ ์ด์ ์๊ฐย ๏ผET๏ผ
์์ธ๋ 15๋ถ ์ง์ฐ๋ฉ๋๋ค
USD
0.000
์ฅ์ ๊ฑฐ๋ย ย (ET)
2.98B
์๊ฐ์ด์ก
์์ค
P/E TTM
Enliven Therapeutics Inc
48.943
-1.807
-3.56%
๊ฐ์
๊ธ์ต
ํ ๋ก
๋ถ์
ํ์ฌ
ํ๋กํ
์์ต
์ฃผ์ฃผ
๊ธฐ์
๊ฐ์
๊ธ์ต
ํ ๋ก
๋ถ์
ํ์ฌ
ํ๋กํ
์์ต
์ฃผ์ฃผ
๊ธฐ์
์ฃผ์ ๋ณด์ ํต๊ณ
๋ง์ง๋ง ์ ๋ฐ์ดํธ: Sun, May 10
๋ง์ง๋ง ์ ๋ฐ์ดํธ: Sun, May 10
์ฃผ์ฃผ
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
OrbiMed Advisors, LLC
13.07%
Fidelity Management & Research Company LLC
11.36%
Commodore Capital LP
7.71%
Vestal Point Capital, LP
6.29%
Fairmount Funds Management LLC
6.09%
๊ธฐํ
55.48%
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
OrbiMed Advisors, LLC
13.07%
Fidelity Management & Research Company LLC
11.36%
Commodore Capital LP
7.71%
Vestal Point Capital, LP
6.29%
Fairmount Funds Management LLC
6.09%
๊ธฐํ
55.48%
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
๋น์จ
Investment Advisor/Hedge Fund
27.26%
Investment Advisor
25.47%
Hedge Fund
24.48%
Private Equity
13.57%
Venture Capital
9.65%
Individual Investor
7.52%
Research Firm
1.28%
Bank and Trust
0.22%
Pension Fund
0.20%
๊ธฐ๊ด ์ฃผ์ ๋ณด์
๎
๋ง์ง๋ง ์ ๋ฐ์ดํธ: Wed, Apr 1
๋ง์ง๋ง ์ ๋ฐ์ดํธ: Wed, Apr 1
๋ณด๊ณ ๊ธฐ๊ฐ
๊ธฐ๊ด ์
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
2026Q1
307
64.93M
106.61%
+111.13K
2025Q4
272
61.24M
108.69%
+16.75K
2025Q3
277
61.22M
110.73%
-393.73K
2025Q2
267
61.46M
92.82%
+10.53M
2025Q1
244
50.77M
106.67%
-1.54M
2024Q4
228
50.41M
102.41%
+2.15M
2024Q3
215
48.25M
108.47%
-410.38K
2024Q2
201
48.86M
98.67%
+5.74M
2024Q1
171
44.61M
88.34%
+3.35M
2023Q4
161
39.15M
98.50%
-34.37K
๋ ๋ณด๊ธฐ
์ฃผ์ฃผ ํ๋
๎
์ด๋ฆ
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
Chg %
๋ ์ง
OrbiMed Advisors, LLC
7.96M
13.31%
--
--
Dec 31, 2025
Fidelity Management & Research Company LLC
6.92M
11.57%
-20.94K
-0.30%
Dec 31, 2025
Commodore Capital LP
4.69M
7.85%
--
--
Dec 31, 2025
Vestal Point Capital, LP
3.83M
6.4%
+2.67M
+230.17%
Dec 31, 2025
Fairmount Funds Management LLC
3.71M
6.21%
--
--
Dec 31, 2025
Polar Capital LLP
3.51M
5.88%
+418.67K
+13.53%
Dec 31, 2025
VR Adviser, LLC
3.23M
5.4%
--
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
3.13M
5.23%
+9.79K
+0.31%
Dec 31, 2025
Dalton Barbara J
2.54M
4.24%
+2.54M
--
Jun 30, 2025
Janus Henderson Investors
1.67M
2.8%
-121.86K
-6.79%
Dec 31, 2025
๋ ๋ณด๊ธฐ
๊ด๋ จ ETF
๎
๋ง์ง๋ง ์ ๋ฐ์ดํธ: Sat, Dec 6
๋ง์ง๋ง ์ ๋ฐ์ดํธ: Sat, Dec 6
์ด๋ฆ
๋น์จ
State Street SPDR S&P Pharmaceuticals ETF
1.63%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.29%
Tema Oncology ETF
1.15%
Virtus LifeSci Biotech Clinical Trials ETF
0.81%
iShares U.S. Pharmaceuticals ETF
0.38%
iShares Micro-Cap ETF
0.19%
ProShares Ultra Nasdaq Biotechnology
0.16%
Invesco Nasdaq Biotechnology ETF
0.13%
Fidelity Fundamental Small-Mid Cap ETF
0.12%
iShares Biotechnology ETF
0.08%
๋ ๋ณด๊ธฐ
State Street SPDR S&P Pharmaceuticals ETF
๋น์จ
1.63%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
๋น์จ
1.29%
Tema Oncology ETF
๋น์จ
1.15%
Virtus LifeSci Biotech Clinical Trials ETF
๋น์จ
0.81%
iShares U.S. Pharmaceuticals ETF
๋น์จ
0.38%
iShares Micro-Cap ETF
๋น์จ
0.19%
ProShares Ultra Nasdaq Biotechnology
๋น์จ
0.16%
Invesco Nasdaq Biotechnology ETF
๋น์จ
0.13%
Fidelity Fundamental Small-Mid Cap ETF
๋น์จ
0.12%
iShares Biotechnology ETF
๋น์จ
0.08%